profile-img
Moffitt Cancer Center

@MoffittNews

Moffitt Cancer Center is a global leader in patient care, research and education with a mission to contribute to the prevention and cure of cancer.

calendar_today19-03-2009 15:57:22

18,7K Tweets

49,5K Followers

3,7K Following

Moffitt Cancer Center(@MoffittNews) 's Twitter Profile Photo

Timothy Yap, PhD, of MD Anderson Cancer Center presents first-in-human phase 1/2a trial of first-in-class saruparib monotherapy. The new generation PARP inhibitor demonstrated a
promising ORR and PFS in patients with certain HRR-deficient .

Timothy Yap, PhD, of @MDAndersonNews presents first-in-human phase 1/2a trial of first-in-class saruparib monotherapy. The new generation PARP inhibitor demonstrated a promising ORR and PFS in patients with certain HRR-deficient #breastcancer. #AACR24
account_circle